key: cord-0886779-evllgl7u
authors: Gupta, Kapil; Toelzer, Christine; Kavanagh Williamson, Maia; Shoemark, Deborah K.; Oliveira, A. Sofia F.; Matthews, David A.; Almuqrin, Abdulaziz; Staufer, Oskar; Yadav, Sathish K.N.; Borucu, Ufuk; Garzoni, Frederic; Fitzgerald, Daniel; Spatz, Joachim; Mulholland, Adrian J.; Davidson, Andrew D.; Schaffitzel, Christiane; Berger, Imre
title: Structure and mechanism of SARS-CoV-2 Spike N679-V687 deletion variant elucidate cell-type specific evolution of viral fitness
date: 2021-05-11
journal: bioRxiv
DOI: 10.1101/2021.05.11.443384
sha: 53e49f6eeda8023a7b32e38372b497c528b95508
doc_id: 886779
cord_uid: evllgl7u

As the global burden of SARS-CoV-2 infections escalates, so does the evolution of viral variants which is of particular concern due to their potential for increased transmissibility and pathology. In addition to this entrenched variant diversity in circulation, RNA viruses can also display genetic diversity within single infected hosts with co-existing viral variants evolving differently in distinct cell types. The BriSΔ variant, originally identified as a viral subpopulation by passaging SARS-CoV-2 isolate hCoV-19/England/02/2020, comprises in the spike glycoprotein an eight amino-acid deletion encompassing the furin recognition motif and S1/S2 cleavage site. Here, we analyzed the structure, function and molecular dynamics of this variant spike, providing mechanistic insight into how the deletion correlates to viral cell tropism, ACE2 receptor binding and infectivity, allowing the virus to probe diverse trajectories in distinct cell types to evolve viral fitness. Teaser SARS-CoV-2 can exploit different cell types to diversify and evolve virus variants distinct in infectivity and structure.

RNA sequencing confirmed that the limiting dilution yielded WT SARS-CoV-2 from Caco-2 cells. In contrast, BriS was selected for in Vero E6 cells (Fig. 1A) as expected (11) . The amounts of the BriS and WT viruses was estimated based on genome equivalence by qRT-PCR and used for infection of (Fig. 1C) . Thus, the lack of the TMPRSS2 protease contributes to, but is not the only reason why the BriS variant infects Vero E6 cells better than WT virus. Differences in the route of cell entry either via fusion at the plasma membrane or receptor mediated endocytosis (20) (21) (22) may account for this result. Interestingly our results using Vero E6/TMPRSS2 cells are similar to those of Zhu et al (18) comparing the replication of WT SARS-CoV-2 and a virus (Sdel) containing a 7 amino acid deletion encompassing the furin cleavage site but differ from those based on a competition assay between the WT and PRRA viruses, which infected Vero E6/TMPRSS2 cells equally well (19) . Despite the fact that we selected WT SARS-CoV-2 from Caco-2 cells by serial dilution, BriS infected Caco-2 cells better than the WT at high virus titers; 25% versus 10% infected cells were observed with the starting dilutions of BriS and WT, respectively (Fig. 1D) . Overexpression of the ACE2 receptor in Caco-2 cells led to 70% infection of cells up to 32-fold dilution of WT, whereas only about 35% of cells could be infected by the BriS variant at the same dilution (Fig. 1E) . Thus, both the WT and BriS viruses infect Caco-2 cells better when ACE-2 expression was increased, but the improvement for WT virus was substantially higher. Calu-3 lung cells were infected about 2-fold better by WT virus for all dilutions except the starting dilutions (Fig. 1F) , corroborating the contribution of the furin site in SARS-CoV-2 S to improved infection of lung cells (19) .

Next, we tested neutralization of the WT and BriS viruses. No difference was found in neutralization of the two viruses when Vero E6/TMPRSS2 and Vero E6 cells were infected with equal amounts of infectious virus based on cell infectivity, in the presence of a commercial antibody binding the RBD (Fig. 1G ) or human serum from a convalescent COVID-19 patient ( fig. S2 ), respectively, indicating that both virus species were neutralized with equal potency by the antibodies tested.

To understand the structural impact of the deletion of the furin cleavage site on SARS-CoV-2 S architecture, we produced the ectodomain of BriS by MultiBac/insect cell expression as a secreted trimer (23) . We purified the protein by affinity purification and size exclusion chromatography ( fig.   S3A ,B) We used the peak fraction from SEC for negative stain EM quality control ( fig. S3C ) and cryogenic electron microscopy (cryo-EM) ( fig. S4 , table S1). We determined the BriS structure without applying symmetry (C1) at 3.0 Å resolution ( fig. S5A ). In our analysis, all BriS particles exhibited the locked conformation of the S trimer we had described previously (23) . After applying 3fold symmetry (C3) we obtained a 2.8 Å cryo-EM map (Fig. 2, fig. S5B ). In this compact locked S conformation, the receptor-binding motif (RBM) is buried inside the RBD trimer obstructing ACE2 receptor binding ( fig. S6A ). The RBD also comprises an RGD motif implicated in integrin-mediated cell entry (24) . The three RGD motifs present in BriS are buried at the interfaces between the RBDs ( fig. S6B ) and thus will be likewise less accessible in the locked form, similar to the RBMs. We previously found a free-fatty acid (FFA) binding pocket in the locked structure of SARS-CoV-2 S, and identified a small molecule tightly bound in the pocket, with the molecular mass of linoleic acid (LA) as determined by electron-spray ionization mass-spectroscopy (ESI-MS) (23) . In the present locked structure of BriS, all three pockets are again occupied by a small molecule ( Fig. 2A,B) . Using hydrophilic interaction liquid chromatography followed by tandem mass spectrometry (HILIC-MS-MS) as an orthogonal method and LA as a calibration standard, we confirmed that the BriS S samples contain LA (Fig. 2C ). LA is bound in a bi-partite binding pocket where one RBD provides a hydrophobic pocket to accommodate the hydrocarbon tail, while residues R408 and Q409 of the adjacent RBD provide a polar lid coordinating the carboxy head group of LA (Fig. 2B ). In the BriS C1 structure, we identified the same tube-shaped density in all three RBD domains ( fig. S6A ), indicating high occupancy of all three pockets. Using masked 3D classification, we scrutinized the data set for potential heterogeneity in LA binding and found that at least 95% of the RBDs were LA-bound in our structure ( fig. S7 ).

We compared our BriS structure with previously solved S structures revealing additional features (Fig. 2) . Disulfide bonds play a crucial role in stabilizing the S trimer and individual domains.

Five out of 14 annotated disulfide bonds in S (25) stabilize the RBD including the disulfide bond linking C336 and C361 (Fig. 2D ,E). Three arginine R1031 residues in our construct (R1039 in WT S), one each from the three polypeptide chains in the S trimer, form a hydrogen bond cluster (Fig. 2G ). In this cluster, the arginine residues are symmetrically arranged around the central trimer axis with short range contacts of 4.65 Å present between the carbon atoms of the guanidino groups. The guanidinium planes stack parallelly on top of the aromatic plane of the juxtaposed F1034, and a salt bridge is formed to E1023 of the adjacent S polypeptide chain (Fig. 2G) . R1031, E1023 and F1034 are conserved in all human coronaviruses, highlighting their central importance. In the vicinity, a disulfide bond is formed by conserved residues C1024 and C1035, arranging E1023 and F1034 at the required distance and in the proper conformation to stabilize the R1031-mediated interaction (not shown). Opening of the RBDs was shown to induce an asymmetry in the trimer structure that breaks this H-bond cluster (8, 26) . LA binding in the FFA-pockets induces conformational changes to the residues surrounding the FFAbinding pocket in the RBD and beyond, including the NTD, SD2 and the fusion peptide proximal region (FFPR). Re-organization of SD2 in the locked structure results in a stabilization of the region around R634 (Fig. 2K ). This arginine residue is stabilized by π-stacking on Y829 (Y837) and thus connects to the FPPR of the neighboring subunit. Such π-stacking interactions were observed in a previous structure which had an intact furin site, and also (unassigned) density in the FFA-binding pocket (10) . R634 stacking to Y829 is additionally stabilized by a hydrophobic interaction to L833 (Fig. 2K ). Fixed in a rigid position through these interactions, C832 (C840) can form a disulfide bond to C843 (C851) which additionally stabilizes the FPPR (Fig. 2F ). This disulfide bond-mediated stabilization of the FPPR has been described in a cryo-EM structure of full-length S protein (9) . We scrutinized the deposited EM density of this structure and found it contained unassigned density in the FFA-binding pocket, indicating a ligand, presumably a free-fatty acid (9) . In the meantime, further structures became available which adopt a locked conformation and comprise assigned or unassigned density in the FFA-binding pocket. The sandwiched R634 is present in all; fully modelled in five structures (PDBID 6ZB5, 7JJI, 6ZGI, 6ZGE, 6XR8), not modelled in one structure but evident in the density (PDBID 6ZP2) and in a further structure with the density (but not the model) supporting the sandwiched arginine (PDBID 7DF3). In comparison, S structures in the closed, but not locked, conformation, where the FFA-binding pocket does not contain any ligand density, show no π-stacking interaction of R634. Instead, in these structures (PDBID 6VXX and 6ZP1) residues 620 to 640 as well as parts of the FPPR are disordered, and residues Y636 and R634 adopt different conformations.

Our BriS construct harbors WT residues K978 and V979 (K986 and V987 in WT S), which often are mutated to prolines to stabilize S in the prefusion state. A closeup view of this region in the BriS shows that the valine fits well into the density while the lysine sidechain appears to be somewhat flexible (Fig. 2H ). Importantly, BriS lacks 8 amino acids including the furin cleavage site and the S1/S2 cleavage site located on a flexible loop. This loop is now shorter due to the deletion and thus more rigid in BriS, as evidenced by density in the C1 map which allowed to build a poly-alanine chain (Fig. 2I) .

We analyzed N-glycosylation of BriS and identified no significant changes compared to previous S structures (table S2) . Interestingly, WT residues S673, T676, T678 and S680 close to the furin site are all candidates for O-glycosylation which is dependent on proline P681 (27) . It was shown that O-glycosylation of these residues negatively affects furin cleavage, contributing to S stability and infectivity (27) . P681 and S680 are deleted in BriS and P681 is mutated in other lineages, including the B.1.1.7 variant that emerged in Kent, UK (28) and rapidly spread globally. The enzymes responsible for O-glycosylation (GALNTs) are expressed differently in different cell types (29) , and the absence of P681 in BriS could thus contribute to the observed dominance of this variant in certain cell types.

The cryo-EM structure of BriS showed only particles in the locked conformation in which RBM binding to ACE2 is obstructed ( Fig. 2 ; figs S4-S6). In the cell-based assays, however, BriS virus is infectious (Fig. 1 ). To address this apparent discrepancy, we biochemically analyzed the interaction of a range of S proteins with the ACE2 receptor. We compared BriS binding to ACE2 with S protein lacking the RBM, S protein where the furin site residues are replaced by an alanine (S RRAR->A ), uncleaved WT S (S RRAR ) and furin-cleaved WT S (S RRAR* ) (Fig. 3A, table S3 ). ELISA using a surrogate virus neutralization test kit (sVNT) indicated that all S proteins efficiently bind ACE2, except the S protein lacking the RBM used as a control (Fig. 3B ). For the other S proteins, half-maximal binding was observed between 64 and 128 nM S protein in the assay. We determined the dissociation constant (KD) of BriS and ACE2 by surface plasmon resonance (SPR) with biotinylated ACE2 immobilized on a streptavidin-coated chip (Fig. 3C, fig. S8 ). Binding of BriS (KD=2.5 nM) to ACE2 is only slightly weaker as compared to S RRAR->A (1.4 nM) (23) . In agreement, the maximal RU values, indicating mass deposited on the ACE2-coated chip, were virtually identical for BriS, S RRAR->A and uncleaved WT S ( Fig. 2D, fig. S8A ,B). The partially cleaved WT S yielded lower RUmax signals, possibly due to partial dissociation of the S trimer and binding of the smaller S1 fragment to ACE2. Our biochemical assays thus establish that the BriS trimer can adopt an open, ACE2-binding competent conformation, which however was not observed on the cryo-EM grids. This finding is in agreement with our results that the Thus, LA binding significantly stabilizes the locked conformation of both, WT S (P=0.0027) and BriS (P=0.0024). Importantly, LA apparently shifts the equilibrium favoring the locked conformation for BriS more than for WT S (P = 0.039) (Fig. 4H ). This hypothesis is supported by our cryo-EM structure which shows that virtually all BriS trimers were LA-bound and in the locked conformation (Fig. 2) .

We next performed 180 short dynamical-nonequilibrium simulations to analyze intra-spike communication and identify any structural networks connecting the FFA-binding pocket to functionally important motifs within WT S and BriS (Fig. 5, fig. S9 ). In these simulations, the LA molecules were removed from the FFA pockets and the response of the systems to this perturbation was determined using the Kubo-Onsager approach (30) (31) (32) . The simulations revealed a cascade of structural changes occurring in response to the LA removal and highlight the route by which such changes are transmitted through the S protein (fig. S10, S11). Strikingly, we find that the furin cleavage site responds swiftly to LA in the WT S, despite being 40 Å away from the FFA pocket ( and S1/S2 cleavage sites. These results indicate that that BriS has different allosteric and dynamical behaviour from the WT S.

We investigated here the structure and functional characteristics of BriS. We find important similarities between BriS, an engineered PRRA SARS-CoV-2 in which only the four residues of the furin cleavage site had been removed by reverse genetics (19) and Sdel, a variant containing a cell passage acquired deletion encompassing the furin cleavage site (18) . All deletion variants replicate substantially better in Vero E6 cells but show impaired replication in Calu-3 cells -underscoring that WT SARS-CoV-2 evolved to efficiently infect and replicate in respiratory cells. At the same time, we find differences highlighting the impact of the exact sequence context of the deletion: expression of serine protease TMPRSS2 in Vero E6 cells reduced the replication advantage of PRRA SARS-CoV-2 (19), but not of BriS or Sdel (18) . In our experiments, BriS and WT SARS-CoV-2 both exhibited increased infection and replication in Vero E6/TMPRSS2 cells, but BriS retained higher infection and replication rates as compared to WT virus (Fig. 1C) . Importantly, the engineered PRRA virus required more antibody for neutralization of the virus compared to WT SARS-CoV-2, while monoclonal antibody and human sera neutralize BriS and WT SARS-CoV-2 with equal efficacy (Fig.   1G, fig. S2 ). Interestingly, ACE2 receptor overexpression in Caco-2 cells improved the infection and replication of BriS and WT SARS-CoV-2 as compared to Caco-2 cells with a lower constitutive expression of ACE2 (Fig. 1D,E) .

Mechanistically, the different infectivity of cells expressing high levels of TMPRSS2 is probably explained by the fact that WT SARS-CoV-2 S is cleaved at the furin cleavage site (S1/S2 cleavage), which primes S for cleavage with TMPRSS2 (at S2´) resulting in activation of the fusion peptide (1). The virus can then fuse at the plasma membrane to enter cells (20, 22) . It has been shown that the furin-cleaved S can also interact with neuropilin (NRP1) following the CendR rule, potentially enhancing viral entry (34, 35) . Lacking these modalities, BriS is likely taken up by receptor-mediated endocytosis and then potentially cleaved by an intracellular protease before fusing via the endosome.

Thus, Calu-3 cells which express TMPRSS2 are better infected by WT virus, and they replicate WT virus more efficiently than BriS virus. In addition, intracellular defence pathways exist such as the interferon-induced transmembrane proteins (IFITMs) that may be more active against virus entering through the endosome rather than fusing at the plasma membrane (36) . Vero E6 cells express low very levels of TMPRSS2, therefore WT virus cannot enter efficiently by fusing at the plasma membrane, and it has recently been suggested that WT SARS-CoV-2 is also taken up by receptor-mediated endocytosis in these cells (21) . Our data suggests this process is more efficient for the BriS virus.

Notably, Vero E6 cells are deficient in the interferon pathway, and entry via the endosome may not be inhibited in these cells (17) . We hypothesize that deletion of the furin cleavage site potentially results in a more stable viral particle secreted from cells, with increased expression of full-length BriS in a prefusion state. At the same time, we cannot exclude further impact of the BriS variant on intracellular replication and immunogenicity.

The cryo-EM structure revealed BriS trimer in an LA-bound, locked conformation ( Fig. 2) which obstructs both ACE2 binding and integrin-mediated cell entry. We observe two motifs stabilizing LA-bound locked BriS which appear to be characteristic for this S conformation (PDBID 6ZB5, 7JJI, 6ZGI, 6ZGE, 6XR8, 6ZP2, 7DF3), namely the H-bond cluster formed by R1031 stabilizing the trimer interface (Fig. 2G ) and the cation-π interaction between R634 and Y829 stabilizing the interaction of S1 with the S2 of the adjacent trimer subunit (Fig. 2K ). Y829 is part of the FPPR motif which is folded in the locked, but not in the closed conformation of S (33). R634 is part of an extended loop structure that holds the FPPR in place, and alterations in this region, for instance the D614G S mutation, favor opening of the RBDs and disorder the FPPR (37), possibly exposing the S2´ cleavage site upstream of the fusion peptide (9) .

Biochemical interaction assays show that BriS protein binds ACE2 with comparable affinity as S protein that does not have the deletion (Fig. 3) . Thus, BriS can evidently adopt open conformation(s), consistent with the infectivity of the BriS variant (Fig. 1) . We conclude that cryo-EM analysis may not fully reflect the dynamics of the S trimer which is subject to a range of stabilizing and destabilizing modalities (38) . Moreover, WT and other S proteins previously analyzed often contain a variety of alterations such as proline mutations stabilizing the prefusion conformation which we did not include in our construct (table S3) . Further, a decreased stability of open BriS may be due to the more rigid loop (T676-Q682) lacking 8 amino acids including two protease cleavage sites. In agreement with this, it has been suggested that furin cleavage facilitates the opening of WT S (10). Our study indicates that the locked BriS conformation is stabilized as compared to WT S by the additional interactions we described, and the shortened loop may assist to keep these properly in place. Thus, BriS may have different opening kinetics from WT S and other variants, which however does not noticeably affect the equilibrium binding constant to ACE2. Moreover, it has been shown that the presence of ACE2 receptors enhances the opening of the RBDs (39).

Our molecular dynamics simulations clearly support different stability and kinetics of RBD opening of LA-bound WT S and BriS. In our targeted MD simulations, LA-bound BriS requires significantly more exertion of force as compared to WT S, to adopt an open conformation (Fig. 4) .

Nonequilibrium MD simulations show that in WT S, both the furin site and the V622-L629 region respond rapidly to LA removal; after 0.1 ns conformational changes are observed in both regions (Fig.   5 ). In contrast, in BriS, a fast conformational response is only observed for the V622-L629 region, indicating effectively no communication between the shortened loop and the LA pocket (Fig. 5) . The nonequilibrium simulations confirm allosteric connections between the LA pocket and regions V622-L629, D808-S813 and the FPPR (Fig. 5) , which are stabilized by R634 π-stacking interaction with Y829 in the FPPR in the locked conformation (Fig. 2K) . LA removal destabilizes these regions. 

isolate hCoV-19/England/02/2020 (GISAID ID: EPI_ISL_407073) and the "Bristol" variant derived from it (BriS) in which spike amino acids 679-687 (NSPRRARSV) were replaced with Ile (11) was grown on either Vero E6 cells or Caco-2 cells and a single virus population was isolated after two rounds of limiting dilution in either cell line ( fig. S1 ). In brief, the virus samples were serially diluted and grown on either Vero E6 or Caco-2 cells in order to favor the growth of the BriS variant or the WT virus respectively. After 5 days incubation, the culture supernatants in wells showing cytopathic effect (CPE) at the highest dilution were again diluted and the process repeated. An aliquot of culture supernatant from wells showing CPE at the highest dilution were used for RNA extraction and RT-PCR using a primer set designed to discriminate the wild type and BriS viruses. Stocks of the purified viruses were produced and titered in Vero E6 cells as described previously (11) . To verify the viral genome sequences, the wildtype and BriS variant virus were grown for 24 h in Vero E6 cells before harvesting the cells and extracting the total RNA with Trizol reagent (ThermoFisher) prior to direct RNA sequencing using an Oxford Nanopore flow cell as previously described (42) . The sequenced reads were aligned to the SARS-CoV-2 genome using minimap2 and the S gene was assessed visually for deletions as well as by an in-house script designed to look for significant deletions in this region and across the whole genome. All work with infectious SARS-CoV-2 was done inside a class III microbiological safety cabinet in a containment level 3 facility at the University of Bristol. 

BriS protein: The construct encoding BriS was synthesized at Genscript (Genscript Inc, New Jersey USA) followed by cloning into pACEBac1 plasmid (Geneva Biotech, Switzerland). The expression construct comprises SARS-CoV-2 spike amino acids 1 to 1208 with the 8 amino acid deletion, followed by a linker, a T4-foldon trimerization domain, another linker and finally an octa-histidine affinity purification tag (table S3) subcloned into pACEBac1 plasmid (Geneva Biotech). S RBM comprises, as described above for BriS, a T4-foldon trimerization domain and an octahistidine tag. In S RBM the ACE2-interacting receptorbinding motif (RBM) in the RBD is deleted and replaced with a glycine-serine rich linker. In addition, S RBM comprises mutations K986P and V987P (table S3) . Protein was produced and purified as described above except that the SEC was performed in 1x PBS at pH 7.5.

S RRAR comprises an intact furin site, mutations K986P and V987P, the T4 foldon trimerization motif and an octa-histidine affinity purification tag (table S3). S RRAR was produced and purified as described above for S RBM .

S RRAR* protein. S RRAR* was obtained by incubating S RRAR with furin protease (New England Biolabs) supplemented with 1mM CaCl2 and incubated at room temperature for 8 hours.

S RRAR->A protein. S RRAR->A protein was produced and purified as described (23) . In S RRAR->A , the furin cleavage site RRAR is replaced with a single alanine residue (44) (table S3) .

4 µL of 0.05 mg/mL SARS-CoV-2 spike protein was applied onto a freshly glow discharged (1 min at 10 mA) CF300-Cu-50 grid (Electron Microscopy Sciences), incubated for 1 min, and manually blotted. 4 µL of 3% uranyl acetate was applied onto the same grid and incubated for 1 min before the solution was blotted off. The grid was loaded onto a FEI Tecnai12 120 kV BioTwin Spirit TEM. Images were acquired at a nominal magnification of 49,000x. 

The dose-fractionated movies were gain-normalized, aligned, and dose-weighted using MotionCor2 (45) . Defocus values were estimated and corrected using the Gctf program (46) . 1,168,229 particles were automatically picked using Relion 3.0 software (47) . The auto-picked particles were extracted with a box size of 110 px (2x binning). Reference-free 2D classification was performed to select welldefined particles. After four rounds of 2D classification a total of 403,252 particles were selected for subsequent 3D classification. The initial 3D model (23) was filtered to 60 Å during 3D classification in Relion using 8 classes. 199,758 particles from Class 6 ( fig. S4 ) were re-extracted with a box size of 220 px (1.05 Å/px, unbinned) and used for subsequent 3D refinement. The 3D-refined particles were then subjected to a second round of 3D classification using 3 classes. Class 2 and 3 were combined yielding 196,832 particles. These particles were subjected to 3D refinement without applying any symmetry. The maps were subsequently subjected to local defocus correction and Bayesian particle polishing in Relion 3.1. Global resolution and B factor (-97.6 Å 2 ) of the map were estimated by applying a soft mask around the protein density, using the gold-standard Fourier shell correlation (FSC) = 0.143 criterion, resulting in an overall resolution of 3.03 Å. C3 symmetry was applied to the Bayesian polished C1 map using Relion 3.1, with 590,496 particles yielding a final resolution of 2.80 Å (B factor of -106.7 Å 2 ). Local resolution maps were generated using Relion 3.1 (fig. S5) .

For model building, UCSF Chimera (48) was used to fit an atomic model of the SARS-CoV2 Spike locked conformation (PDB ID 6ZB5, (23)) into the C3 symmetrized BriS cryo-EM map. The model was rebuilt using sharpened (49) and unsharpened maps in Coot (50) and then fitted into the C1 cryo-EM map. Namdinator (51) and Coot were used to improve the fit and N-linked glycans were built into the density for both models where visible. Restraints for non-standard ligands were generated with eLBOW (52). The model for C1 and C3-symmetrized closed conformation was real space refined with Phenix (53) , and the quality was additionally analyzed using MolProbity (54) and EMRinger (55) , to validate the stereochemistry of the components. Figures were prepared using UCSF chimera and PyMOL (Schrodinger, Inc).

The refined C3 particles stack was expanded 3-fold according to C3 symmetry in Relion. The symmetry-expanded particle stack was then used as input for the masked 3D classification with the focus mask corresponding to individual single chain subunits. Masked 3D classification (56) was performed without alignment using 5 classes for C3-expanded particles ( fig. S7 ). Visual inspection of the 3D classes showed 95% of the chains clustered in the first 3 classes with LA-bound in the hydrophobic pocket within the RBD. 

The SARS-CoV-2 surrogate virus neutralization test (sVNT) kit was obtained from GenScript Inc.

(New Jersey, USA). Serial dilution series were prepared (from 0-4096 nM) of the different purified SARS-CoV-2 S proteins and RBD in PBS pH 7.5. This dilution series was treated as described (23) .

Briefly, dilution series were mixed with the same volume of diluted horseradish peroxidase conjugated RBD (HRP-RBD) from the sVNT kit and incubated at 37ºC for 30 min. 100 L of the mixtures were then added to the ELISA plate wells coated with ACE2, according to the manufacturer's protocol.

Triplicates of each sample were made. The plate was then incubated at 37ºC for 15 min sealed with tape to avoid evaporation and subsequently washed 4 times with 1x wash buffer. The signal was developed by adding tetramethyl-benzidine (TMB) solution to each well, incubating 15 minutes in the dark, followed by adding stop solution supplied with the kit. The absorbance at 450 nm was immediately recorded. The data was plotted using Microsoft excel. Standard deviations from three independent replicates were added as error bars.

Interaction experiments using surface plasmon resonance (SPR) were carried out with a Biacore T200 system (GE Healthcare) according to the manufacturer's protocols and recommendations. Experiments were setup as described before (23) . Briefly, purified biotinylated ACE2 (23) was immobilized on a streptavidin-coated (SA) chip (GE Healthcare) at ~50 RUs. BriS was injected at concentrations of 40nM, 80 nM,120 nM and 160nM. S RBM , S RRAR->A , S RRAR and S RRAR* were injected at 40 nM and 160 nM. Running buffer for all measurements was PBS buffer pH 7.5. Sensorgrams were analyzed and KD, kon and koff values determined with the Biacore Evaluation Software (GE Healthcare), fitting the raw data using a 1:1 binding model. All experiments were performed in triplicates.

The starting structures were comprised of closed WT (WT, P0DTC2) and furin-site deletion (BriS) spike trimers, which had either been equilibrated in the presence of linoleic acid (LA) or not (apo). The target structure was the corresponding S trimer in which a single chain had an RBD in an extended conformation as in EMD-11146 (23) . Exploratory forces were applied to all four systems to find a value that resulted in a distribution of openings when subjected to 10 ns dynamic simulation. Hence starting structures were simulated for 10 ns (each system was replicated 50 times) with restraints of 0.2 kJ/mol/nm force applied to pull the RBD C-alphas to align with those of the corresponding C-alphas of the RBD of the open structure corresponding to (EMD-11146 (23)). The BriS LA-bound system was subjected to a further 50 replicate simulations at k = 0.3 kJ/mol/nm, because it failed to open at k = 0.2 kJ/mol/nm. A paired T-test was applied to test for significance when comparing the data sets.

Protein coordinates were prepared as described (23) . Loops for the unstructured regions of the locked Simulation details: All simulations were performed under the Amber99SB-ildn (61) (62) (63) forcefield in NPT ensembles at 310 K using periodic boundary conditions. We have previously shown that these protocols give structures in good agreement with experiment for the WT spike. Hydrogen atoms, consistent with pH7, were added to the complex. Short-range electrostatic and van der Waals interactions were truncated at 1.4 nm while long range electrostatics were treated with the particlemesh Ewald method and a long-range dispersion correction applied. A simulation box extending 2 nm from the protein was filled with TIP3P water molecules and 150 mM Na + and Clions added to attain a neutral charge overall. Pressure was controlled by the Berendsen barostat and temperature by the V- 

To map the structural changes associated with the LA removal from the FFA-binding pocket in the WT and BriS spike proteins, two sets of 90 dynamical-nonequilibrium simulations were performed. In this approach, the response of a system to a perturbation is directly computed by calculating the difference of a given property between simulations with and without a perturbation. Subtracting the perturbed and unperturbed pairs of simulations at a given time, and averaging the results over many replicates, allows for the identification of the events associated with signal propagation and the determination the statistical significance of the observation (30) (31) (32) . The perturbation was generated by the (instantaneous) removal of LA from the FFA-binding pocket. Note that the perturbation used here is not intended to represent the physical process of unbinding, but rather is designed to force the system out of equilibrium and drive a rapid response within the protein, as it adapts to LA removal. A graphical representation of the procedure is shown in Figure S9 . Three equilibrium MD simulations, 200 ns each, were performed for the locked form of the unglycosylated head region of the WT and BriS S proteins with LA bound. The simulation conditions for the equilibrium and dynamicalnonequilibrium simulations were identical to those described in (23, 66) . The starting conformations for the nonequilibrium simulations were obtained from the equilibrated part of the equilibrium LAbound simulations. Conformations were taken every 5 ns, and each of the LA molecules were (instantaneously) removed from all the FFA-binding pockets. The resulting apo system was then simulated for 5 ns (fig. S10, S11). 180 apo dynamical-nonequilibrium simulations were performed (90 simulations each for BriS and WT S). Three positive ions were also removed from the solvent to maintain the electroneutrality of the systems (required for the PME method (67)).

The Kubo-Onsager approach (30-32) was used to extract and characterize the structural changes in the protein associated with LA removal. The response to perturbation is directly measured by averaging a The statistical significance of the structural changes identified here is demonstrated by a low standard error of the averages (data not shown).

Statistics. Statistical significance was determined by calculating standard deviations following standard mathematical formulae (31) . Standard deviations were calculated from independent triplicates unless indicated otherwise. 

The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade

Structural basis of receptor recognition by SARS-CoV-2

Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Distinct conformational states of SARS-CoV-2 spike protein

SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects

Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein

SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology

SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells

SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients

Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction

SARS-CoV-2 Bris Page

Natural transmission of bat-like SARS-CoV-2PRRA variants in COVID-19 patients

The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets

A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry

Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis

Cell entry mechanisms of SARS-CoV-2

Drug repurposing screens reveal cell-type-specific entry pathways and FDAapproved drugs active against SARS-Cov-2

SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development

Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein

Biological and Clinical Consequences of Integrin Binding via a Rogue RGD Motif in the SARS CoV-2 Spike Protein

UniProt: the universal protein knowledgebase in 2021

A graph-based approach identifies dynamic H-bond communication networks in spike protein S of SARS-CoV-2

Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation. bioRxiv

Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family

Thought-experiments by molecular dynamics

Identification of the Initial Steps in Signal Transduction in the α4β2 Nicotinic Receptor: Insights from Equilibrium and Nonequilibrium Simulations

SARS-CoV-2 Bris Page

Non-equilibrium by molecular dynamics: a dynamical approach

Structures and function of locked conformations of SARS-CoV-2 spike

Neuropilin-1 is a host factor for SARS-CoV-2 infection

Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity

The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2

Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant

The SARS-CoV-2 spike protein: balancing stability and infectivity

Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion

Decay characteristics of HIV-1-infected compartments during combination therapy

Evolution in spatially mixed host environments increases divergence for evolved fitness and intrapopulation genetic diversity in RNA viruses

Deep splicing plasticity of the human adenovirus type 5 transcriptome drives virus evolution

Protein complex expression by using multigene baculoviral vectors

A serological assay to detect SARS-CoV-2 seroconversion in humans

MotionCor2: anisotropic correction of beam-induced motion for improved cryoelectron microscopy

Gctf: Real-time CTF determination and correction

RELION: implementation of a Bayesian approach to cryo-EM structure determination

SARS-CoV-2 Bris Page

Visualizing density maps with UCSF Chimera

Automated map sharpening by maximization of detail and connectivity

Features and development of Coot

Namdinator -automatic molecular dynamics flexible fitting of structural models into cryo-EM and crystallography experimental maps

electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation

Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix

MolProbity: all-atom structure validation for macromolecular crystallography

EMRinger: side chain-directed model and map validation for 3D cryo-electron microscopy

Characterisation of molecular motions in cryo-EM single-particle data by multi-body refinement in RELION

UCSF Chimera--a visualization system for exploratory research and analysis

Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega

PROCHECK -a program to check the stereochemical quality of protein structures

ACPYPE -AnteChamber PYthon Parser interfacE

Development and testing of a general amber force field

The Amber biomolecular simulation programs

Improved side-chain torsion potentials for the Amber ff99SB protein force field

SARS-CoV-2 Bris Page

GROMACS: fast, flexible, and free

VMD: visual molecular dynamics

Molecular Simulations suggest Vitamins, Retinoids and Steroids as Ligands of the Free Fatty Acid Pocket of the SARS-CoV-2 Spike Protein*

A smooth particle mesh Ewald method

W is supported by MRC grants MR/R020566/1 and MR/V027506/1 (awarded to A.D.D). A.J.M. is supported the British Society for Antimicrobial Chemotherapy (BSAC-COVID-30) and the EPSRC (EP/M022609/1, CCP-BioSim). I.B. acknowledges support from the EPSRC Future Vaccine Manufacturing and Research Hub (EP/R013764/1). C.S. and I.B

performed all live virus CL3 work and analyzed data. D.A.M and A.A. performed direct RNA sequencing and analysis of sequence data

Competing interests: The authors declare competing interests. F.G. and I.B. report shareholding in

and I.B. report shareholding in Halo Therapeutics Ltd related to this Correspondence

Data and materials availability: Datasets and coordinates generated during the current study have been deposited in the Electron Microscopy Data Bank (EMDB) under accession numbers EMD-12818

Reagents are available from C.S. and I.B. under a material transfer agreement with the

We thank all members of the Berger